| scholarly article | Q13442814 |
| P50 | author | Adam D. McIntyre | Q120488225 |
| Robert A. Hegele | Q58046422 | ||
| P2093 | author name string | Jian Wang | |
| John F Robinson | |||
| Henian Cao | |||
| David E Carter | |||
| Joseph B Dubé | |||
| Austin MacDonald | |||
| Christopher T Johansen | |||
| Melissa N Loyzer | |||
| P2860 | cites work | A molecular genetic service for diagnosing individuals with familial hypercholesterolaemia (FH) in the United Kingdom | Q63314547 |
| The molecular basis of familial hypercholesterolemia in The Netherlands | Q77543744 | ||
| In search of low-frequency and rare variants affecting complex traits | Q24618492 | ||
| Biological, clinical and population relevance of 95 loci for blood lipids | Q24622541 | ||
| Mechanisms and genetic determinants regulating sterol absorption, circulating LDL levels, and sterol elimination: implications for classification and disease risk | Q27003094 | ||
| Sequencing technologies - the next generation | Q27860568 | ||
| Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia | Q28295479 | ||
| Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia | Q28943439 | ||
| ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data | Q29547161 | ||
| ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing | Q29616235 | ||
| Massively parallel sequencing approaches for characterization of structural variation | Q34121475 | ||
| Molecular genetic testing and the future of clinical genomics | Q34345162 | ||
| Clinical whole-exome sequencing for the diagnosis of mendelian disorders | Q34413680 | ||
| Thematic review series: Adipocyte Biology. Lipodystrophies: windows on adipose biology and metabolism | Q34610713 | ||
| Excess of rare variants in non-genome-wide association study candidate genes in patients with hypertriglyceridemia | Q35784042 | ||
| The UCSC Genome Browser database: extensions and updates 2013. | Q36491237 | ||
| Description of a large family with autosomal dominant hypercholesterolemia associated with the APOE p.Leu167del mutation | Q36802138 | ||
| Opportunities and challenges for the integration of massively parallel genomic sequencing into clinical practice: lessons from the ClinSeq project | Q37216033 | ||
| Personalized genomic disease risk of volunteers | Q37240475 | ||
| Plasma lipoproteins: genetic influences and clinical implications | Q37367246 | ||
| First FDA authorization for next-generation sequencer | Q37403376 | ||
| Novel LPL mutations associated with lipoprotein lipase deficiency: two case reports and a literature review | Q37417491 | ||
| Next-generation sequencing in the clinic: are we ready? | Q37478694 | ||
| The diagnosis and management of monogenic diabetes in children and adolescents | Q37597454 | ||
| Exome sequencing and directed clinical phenotyping diagnose cholesterol ester storage disease presenting as autosomal recessive hypercholesterolemia | Q37727765 | ||
| Molecular mechanisms of human lipodystrophies: from adipocyte lipid droplet to oxidative stress and lipotoxicity. | Q37851652 | ||
| Genetic bases of hypertriglyceridemic phenotypes | Q37868881 | ||
| How next-generation sequencing is transforming complex disease genetics | Q38055956 | ||
| Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study | Q43418707 | ||
| Targeted next-generation sequencing can replace Sanger sequencing in clinical diagnostics | Q45736566 | ||
| Next-generation sequencing: methodology and application | Q46756992 | ||
| Western Database of Lipid Variants (WDLV): a catalogue of genetic variants in monogenic dyslipidemias | Q48039670 | ||
| P433 | issue | 4 | |
| P921 | main subject | dyslipidemia | Q66291209 |
| P304 | page(s) | 765-772 | |
| P577 | publication date | 2014-02-06 | |
| P1433 | published in | Journal of Lipid Research | Q6295449 |
| P1476 | title | LipidSeq: a next-generation clinical resequencing panel for monogenic dyslipidemias | |
| P478 | volume | 55 |
| Q58046672 | A De Novo Mutation Associated With Mandibular Hypoplasia, Deafness, Progeroid Features, and Lipodystrophy Syndrome in a Family With Werner Syndrome |
| Q38757145 | A Novel APOC2 Missense Mutation Causing Apolipoprotein C-II Deficiency With Severe Triglyceridemia and Pancreatitis. |
| Q51249757 | A Novel Generalized Lipodystrophy-Associated Progeroid Syndrome Due to Recurrent Heterozygous LMNA p.T10I Mutation. |
| Q35602221 | A robust protocol to increase NimbleGen SeqCap EZ multiplexing capacity to 96 samples |
| Q59528278 | Angeborene Störungen im Lipoproteinstoffwechsel |
| Q50183430 | Apolipoprotein C-II: New findings related to genetics, biochemistry, and role in triglyceride metabolism |
| Q36442648 | Association between the DOCK7, PCSK9 and GALNT2 Gene Polymorphisms and Serum Lipid levels |
| Q91913933 | Bioinformatic detection of copy number variation in HNF4A causing maturity onset diabetes of the young |
| Q38366873 | Chylomicronaemia--current diagnosis and future therapies |
| Q38983679 | Clinical evaluation of a hemochromatosis next-generation sequencing gene panel. |
| Q64355726 | Copy Number Variation in GCK in patients with Maturity-Onset Diabetes of the Young |
| Q35100147 | Examining the clinical use of hemochromatosis genetic testing |
| Q38217346 | Exome sequencing: new insights into lipoprotein disorders |
| Q91944007 | Experimental Therapeutics for Challenging Clinical Care of a Patient with an Extremely Rare Homozygous APOC2 Mutation |
| Q90224910 | Genetic Determinants of Myocardial Infarction Risk in Familial Hypercholesterolemia |
| Q58545602 | Genetic and secondary causes of severe HDL deficiency and cardiovascular disease |
| Q38911979 | Genetics of Lipid and Lipoprotein Disorders and Traits |
| Q89925485 | Intermittent chylomicronemia caused by intermittent GPIHBP1 autoantibodies |
| Q88984034 | Large-scale deletions of the ABCA1 gene in patients with hypoalphalipoproteinemia |
| Q89974238 | Molecular diagnosis methods in familial hypercholesterolemia |
| Q57065241 | Multiple Symmetric Lipomatosis (Madelung Disease) in a Large Canadian Family With the Mitochondrial c.8344A>G Variant |
| Q99558341 | Multisystem Progeroid Syndrome With Lipodystrophy, Cardiomyopathy, and Nephropathy Due to an LMNA p.R349W Variant |
| Q48181942 | Mutational analysis of a cohort with clinical diagnosis of familial hypercholesterolemia: considerations for genetic diagnosis improvement. |
| Q36177473 | New Approaches in Detection and Treatment of Familial Hypercholesterolemia |
| Q90100062 | Partial LPL deletions: rare copy-number variants contributing towards severe hypertriglyceridemia |
| Q47121697 | Polygenic determinants in extremes of high-density lipoprotein cholesterol |
| Q38839105 | Progress in the care of common inherited atherogenic disorders of apolipoprotein B metabolism. |
| Q39317912 | Recent advances in genetic testing for familial hypercholesterolemia |
| Q90187956 | Severe Combined Dyslipidemia With a Complex Genetic Basis |
| Q89635414 | Six years' experience with LipidSeq: clinical and research learnings from a hybrid, targeted sequencing panel for dyslipidemias |
| Q92497320 | Targeted next generation sequencing as a tool for precision medicine |
| Q36093235 | Targeted next-generation sequencing to diagnose disorders of HDL cholesterol. |
| Q90602942 | Targeted sequencing identifies novel variants in common and rare MODY genes |
| Q47421459 | The ONDRISeq panel: custom-designed next-generation sequencing of genes related to neurodegeneration |
| Q50194599 | The apolipoprotein C-III (Gln38Lys) variant associated with human hypertriglyceridemia is a gain-of-function mutation |
| Q38208223 | Update on primary hypobetalipoproteinemia |
| Q42993804 | Use of next-generation sequencing to detect LDLR gene copy number variation in familial hypercholesterolemia |
Search more.